Todd C Davis insider trades: Pelthos Therapeutics (PTHS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Todd reports to the SEC
and 1 more company
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | PTHS | ↑ Buy | 35,948 | $27.82 | $1000K | Direct | Jun 15, 2026 (4d) |
| May 9, 2025 | LGND | ↑ Buy | 9,510 | $105.20 | $1.0M | Direct | May 13, 2025 (4d) |
| Aug 8, 2024 | LGND | ↑ Buy | 2,500 | $97.39 | $243K | Direct | Aug 9, 2024 (1d) |
| Sep 22, 2023 | LGND | ↑ Buy | 4,000 | $59.38 | $238K | Direct | Sep 25, 2023 (3d) |
| Feb 10, 2021 | LGND | ↓ Sell | 5,083 | $213.14 | $1.1M | Direct | Feb 12, 2021 (2d) |
| Aug 18, 2020 | BDSI | ↓ Sell | 50,000 | $4.99 | $250K | Direct | Aug 20, 2020 (2d) |
| Apr 28, 2020 | VXRT | ↓ Sell | 60,000 | $3.27 | $197K | Direct | Apr 30, 2020 (2d) |
| Nov 15, 2019 | BDSI | ↓ Sell | 200,000 | $6.11 | $1.2M | Direct | Nov 19, 2019 (4d) |
| Aug 2, 2019 | LGND | ↑ Buy | 1,000 | $93.59 | $94K | Direct | Aug 5, 2019 (3d) |
| Oct 8, 2018 | LGND | ↓ Sell10b5-1 | 2,500 | $253.99 | $635K | Direct | Oct 9, 2018 (1d) |
| Aug 17, 2018 | LGND | ↓ Sell | 9,000 | $239.78 | $2.2M | Direct | Aug 17, 2018 (0d) |
| Feb 27, 2018 | LGND | ↓ Sell | 17,170 | $152.37 | $2.6M | Direct | Feb 27, 2018 (0d) |
| Mar 19, 2014 | LGND | ↓ Sell | 7,500 | $79.57 | $597K | Direct | Mar 20, 2014 (1d) |
| Aug 10, 2011 | LGND | ↑ Buy | 15,000 | $10.90 | $164K | Direct | Aug 11, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTHS insiders
Open-market trades in the last 12 months
About Todd C Davis's insider trades
Todd C Davis is a director at Pelthos Therapeutics (PTHS). Since Aug 10, 2011, Todd has reported 6 open-market purchases worth $2.7M and 8 sales worth $8.8M on SEC Form 4. In the last 12 months: 1 buy ($1000K).
1 sale (7% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (38 filings), option exercises (12 filings), other transactions (6 filings), gifts (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTHS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.